Literature DB >> 16287242

Tumor necrosis factor (TNF)-functionalized nanostructured particles for the stimulation of membrane TNF-specific cell responses.

Susanne Bryde1, Ingo Grunwald, Angela Hammer, Anja Krippner-Heidenreich, Thomas Schiestel, Herwig Brunner, Günter E M Tovar, Klaus Pfizenmaier, Peter Scheurich.   

Abstract

Most members of the tumor necrosis factor (TNF) ligand family occur in both a membrane-bound and a soluble form, which can possess differential bioactivities. The aim of this work was the construction of a synthetic-biological hybrid system consisting of chemically nanostructured core-shell particles with a diameter of 100 nm, 1 microm, or 10 microm and the cytokine TNF to obtain a tool that mimics the bioactivity of naturally occurring membrane-bound TNF. Synthetic core-shell nanoparticles consisting of an inorganic silica core and an ultrathin organic shell bearing a maleimide group at the shell surface which allowed for a covalent and site-directed coupling of CysHisTNF mutants were prepared. The TNF mutants were modified at the N-terminus by PCR cloning by introducing a His-Tag for purification and a free cysteine group for reaction with the particle-attached maleimide group. The resulting nanostructured hybrid particles initiated strong TNF receptor type 2 specific responses, otherwise only seen for the membrane-bound form of TNF, but not the soluble cytokine, thus clearly demonstrating new and membrane TNF-like properties of the bioconjugated soluble TNF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16287242     DOI: 10.1021/bc0501810

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  10 in total

1.  The tumor necrosis factor receptor stalk regions define responsiveness to soluble versus membrane-bound ligand.

Authors:  Christine Richter; Sylvia Messerschmidt; Gerlinde Holeiter; Jessica Tepperink; Sylvia Osswald; Andrea Zappe; Marcus Branschädel; Verena Boschert; Derek A Mann; Peter Scheurich; Anja Krippner-Heidenreich
Journal:  Mol Cell Biol       Date:  2012-04-30       Impact factor: 4.272

Review 2.  Particle-mediated delivery of cytokines for immunotherapy.

Authors:  David A Christian; Christopher A Hunter
Journal:  Immunotherapy       Date:  2012-04       Impact factor: 4.196

3.  Nanoscale arrangement of apoptotic ligands reveals a demand for a minimal lateral distance for efficient death receptor activation.

Authors:  Julia Ranzinger; Anja Krippner-Heidenreich; Tamas Haraszti; Eva Bock; Jessica Tepperink; Joachim P Spatz; Peter Scheurich
Journal:  Nano Lett       Date:  2009-12       Impact factor: 11.189

4.  Targeting the human serotonin transporter (hSERT) with quantum dots.

Authors:  I D Tomlinson; Jerry Chang; Hideki Iwamoto; Louis J De Felice; Randy D Blakely; Sandra J Rosenthal
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2008-02-22

5.  Dendritic cell maturation and survival are differentially regulated by TNFR1 and TNFR2.

Authors:  Anja Krippner-Heidenreich; Catharien M U Hilkens; Nicola J Maney; Gary Reynolds
Journal:  J Immunol       Date:  2014-10-06       Impact factor: 5.422

6.  The critical role of TAK1 in accentuated epithelial to mesenchymal transition in obliterative bronchiolitis after lung transplantation.

Authors:  Aaron Gardner; Andrew J Fisher; Christine Richter; Gail E Johnson; Elizabeth J Moisey; Malcolm Brodlie; Christopher Ward; Anja Krippner-Heidenreich; Derek A Mann; Lee A Borthwick
Journal:  Am J Pathol       Date:  2012-04-21       Impact factor: 4.307

7.  Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2.

Authors:  Roman Fischer; Jessica Marsal; Cristiano Guttà; Stephan A Eisler; Nathalie Peters; John R Bethea; Klaus Pfizenmaier; Roland E Kontermann
Journal:  Sci Rep       Date:  2017-07-26       Impact factor: 4.379

8.  Imaging GABAc receptors with ligand-conjugated quantum dots.

Authors:  Ian D Tomlinson; Hélène A Gussin; Deborah M Little; Michael R Warnement; Haohua Qian; David R Pepperberg; Sandra J Rosenthal
Journal:  J Biomed Biotechnol       Date:  2007

9.  Strategic internal covalent cross-linking of TNF produces a stable TNF trimer with improved TNFR2 signaling.

Authors:  Liqin Ban; Willem Kuhtreiber; John Butterworth; Yoshiaki Okubo; Éva S Vanamee; Denise L Faustman
Journal:  Mol Cell Ther       Date:  2015-08-12

10.  TNF-α Autocrine Feedback Loops in Human Monocytes: The Pro- and Anti-Inflammatory Roles of the TNF-α Receptors Support the Concept of Selective TNFR1 Blockade In Vivo.

Authors:  Jennie M Gane; Robert A Stockley; Elizabeth Sapey
Journal:  J Immunol Res       Date:  2016-09-22       Impact factor: 4.818

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.